Literature DB >> 15763199

Metastatic uveal melanoma.

Arun D Singh1, Ernest C Borden.   

Abstract

Despite achieving great accuracy in correctly diagnosing uveal melanoma in the United States, mortality owing to this tumor has remained unchanged over a period of 25 years from 1973 to 1997. In general, the survival with metastatic uveal melanoma is poor, with a median survival of less than 6 months.

Entities:  

Mesh:

Year:  2005        PMID: 15763199     DOI: 10.1016/j.ohc.2004.07.003

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  26 in total

1.  Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma.

Authors:  Pierre L Triozzi; Wayne Aldrich; Arun Singh
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-25       Impact factor: 4.799

Review 2.  Regional therapies for locoregionally advanced and unresectable melanoma.

Authors:  Evan S Weitman; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2018-05-08       Impact factor: 5.150

Review 3.  Latest developments in the biology and management of uveal melanoma.

Authors:  Sapna P Patel
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

4.  New horizons in melanoma treatment: targeting molecular pathways.

Authors:  Christopher W M Soon; Alain P Algazi; Edward N Cha; Adil I Daud
Journal:  Ochsner J       Date:  2010

5.  Reduction of Nodular Growth Pattern of Metastatic Uveal Melanoma after Radioembolization of Hepatic Metastases.

Authors:  Kevin M Halenda; Ragini R Kudchadkar; David H Lawson; Darren D Kies; Kristen E Zhelnin; Alyssa M Krasinskas; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2015-12-24

6.  Reduced expression of autotaxin predicts survival in uveal melanoma.

Authors:  Arun D Singh; Karen Sisley; Yaomin Xu; Jianbo Li; Pieter Faber; Sarah J Plummer; Hardeep S Mudhar; Ian G Rennie; Patricia M Kessler; Graham Casey; Bryan G Williams
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

7.  Cell growth inhibition in HPV 18 positive uveal melanoma cells by E6/E7 siRNA.

Authors:  Biyun Cun; Xin Song; Renbing Jia; Haibo Wang; Xiaoping Zhao; Bo Liu; Shengfang Ge; Xianqun Fan
Journal:  Tumour Biol       Date:  2013-03-14

8.  Quality of evidence about effectiveness of treatments for metastatic uveal melanoma.

Authors:  James J Augsburger; Zélia M Corrêa; Adeel H Shaikh
Journal:  Trans Am Ophthalmol Soc       Date:  2008

9.  A role for Jag2 in promoting uveal melanoma dissemination and growth.

Authors:  Laura Asnaghi; James T Handa; Shannath L Merbs; J William Harbour; Charles G Eberhart
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-09       Impact factor: 4.799

10.  Value of positron emission tomography/computed tomography in diagnosis and staging of primary ocular and orbital tumors.

Authors:  Ka-Hoi Hui; Margaret L Pfeiffer; Bita Esmaeli
Journal:  Saudi J Ophthalmol       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.